Dtsch Med Wochenschr 2013; 138(49): 2536-2538
DOI: 10.1055/s-0033-1349653
Rheumatologie | Commentary
© Georg Thieme Verlag KG Stuttgart · New York

Weichteilrheumatische Erkrankungen und Schmerztherapie

Soft tissue rheumatic syndromes and treatment of pain
M. Krasselt
1   Sektion Rheumatologie/ Gerontologie, Department für Innere Medizin, Neurologie und Dermatologie, Universitätsklinikum Leipzig
,
C. Baerwald
1   Sektion Rheumatologie/ Gerontologie, Department für Innere Medizin, Neurologie und Dermatologie, Universitätsklinikum Leipzig
› Author Affiliations
Further Information

Publication History

Publication Date:
26 November 2013 (online)

 
  • Literatur

  • 1 Arnold LM, Hirsch I, Sanders P et al. Safety and efficacy of esreboxetine in patients with fibromyalgia. Arthritis Rheum 2012; 64: 2387-2397
  • 2 Foerster BR, Petrou M, Edden RA et al. Reduced insular gamma-aminobutyric acid in fibromyalgia. Arthritis Rheum 2012; 64: 579-583
  • 3 Häuser W, Urrútia G, Tort S et al. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. . Cochrane Database Syst Rev 31.01.2013; (1) CD010292
  • 4 Jensen KB, Loitoile R, Kosek E et al. Patients with fibromyalgia display less functional connectivity in the brain's pain inhibitory network. Mol Pain 2012; 8: 32-38
  • 5 Kim CH, Vincent A, Clauw DJ et al. Association between alcohol consumption and symptom severity and quality of life in patients with fibromyalgia. Arthritis Res Ther 15.03.2013; 15 R42 [Epub ahead of print]
  • 6 Mease PJ, Farmer MV, Palmer RH et al. Milnacipran combined with pregabalin in fibromyalgia. Ther Adv Musculoskel Dis 2013; 5: 113-126
  • 7 Meeus M, Ickmans K, Struyf F et al. Does acetaminophen activate endogenous pain inhibition in chronic fatigue syndrome/fibromyalgia and rheumatoid arthritis?. Pain Physician 2013; 16: E61-E70
  • 8 Mist SD, Firestone KA, Jones KD. Complementary and alternative exercise for fibromyalgia: a meta-analysis. J Pain Res 2013; 6: 247-260
  • 9 Moore RA, Derry S, Aldington D et al. Amitriptyline for neuropathic pain and fibromyalgia in adults. . Cochrane Database Syst Rev 12.12.2012; (12) CD008242
  • 10 Mork PJ, Nilsen TI. Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway. Arthritis Rheum 2012; 64: 281-284
  • 11 Painter J, Crofford LJ. Chronic opioid use in fibromyalgia syndrome. J Clin Rheumatol 2013; 19: 72-77
  • 12 S3-Leitlinie der AWMF. „Fibromyalgiesyndrom“. 2012. http://www.awmf.org/uploads/tx_szleitlinien/041-004l_S3_Fibromyalgiesyndrom_2012-04_01.pdf (letzter Zugriff 10.10.2013)
  • 13 Smith SB, Maixner DW, Fillingim RB et al. Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum 2012; 64: 584-593
  • 14 Younger J, Noor N, McCue R et al. Low-dose naltrexone for the treatment of fibromyalgia. Arthritis Rheum 2013; 65: 529-538